 

Nintedanib Ethanesulfonate Salt For Treatment of idiopathic pulmonary fibrosis CAS number 656247-18-6

Get Latest Price

Payment Type:

L/C,T/T

Incoterm:

FOB

Min. Order:

1 Kilogram

Transportation:

Air

Contact Now

 Chat Now

Product Description

Product Attributes
Supply Ability & Additional Information
Packaging & Delivery

< >

Overview

Product Attributes

Model No.: 656247-18-6

Brand: VOLSENCHEM

Supply Ability & Additional Information

Packaging: AS REQUIRED

Productivity: KGS

Transportation: Air

Place of Origin: CHINA

Supply Ability: TRUE MANUFACTURER

Certificate: ISO

Payment Type: L/C,T/T

Incoterm: FOB

Packaging & Delivery

Selling Units:: Kilogram

Package Type:: AS REQUIRED

Nintedanib Ethanesulfonate Salt CAS number is 656247-18-6 is an oral triple-acting vascular kinase inhibitor developed by Boehringer Ingelheim and was approved by the FDA in October 2014 for the treatment of idiopathic pulmonary fibrosis (IPF), becoming the first tyrosine kinase inhibitor (TKI) approved for the treatment of IPF. Nintedanib Ethanesulfonate Salt has been shown to act on growth factors ,It has potential effects on the pathophysiology of pulmonary fibrosis, the most important of...

Product Categories : Pharmaceutical Intermediates > Anti-Tumor/Cancer

Hot Products

Email to this supplier

*Subject:
*To:

Ms. Amy Cheng
*Email:
*Message:

Your message must be between 20-8000 characters